• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用针对疟原虫的免疫应答进行合理的疫苗设计。

Harnessing immune responses against Plasmodium for rational vaccine design.

机构信息

Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia.

出版信息

Trends Parasitol. 2011 Jun;27(6):274-83. doi: 10.1016/j.pt.2011.01.002. Epub 2011 Apr 30.

DOI:10.1016/j.pt.2011.01.002
PMID:21531627
Abstract

In recent years, groundbreaking advances have been made in understanding the biology of and immune mechanisms against the Plasmodium spp. parasite, the causative agent of malaria. Novel features of the Plasmodium life cycle have been unravelled and immune mechanisms, which take place during both infection and immunization, have been dissected. We have undoubtedly enhanced our knowledge, but the question now is how to use this information to manipulate immune responses against Plasmodium and to develop an efficacious malaria vaccine. In this review, we discuss the latest developments in the field and speculate on how immune responses against Plasmodium could be harnessed for rational vaccine design and application.

摘要

近年来,人们在了解疟原虫(导致疟疾的寄生虫)的生物学和免疫机制方面取得了突破性进展。疟原虫生命周期的新特征已经被揭示,感染和免疫过程中的免疫机制也已经被剖析。我们无疑已经增强了我们的知识,但现在的问题是如何利用这些信息来操纵针对疟原虫的免疫反应,并开发出有效的疟疾疫苗。在这篇综述中,我们讨论了该领域的最新进展,并推测了如何利用针对疟原虫的免疫反应来进行合理的疫苗设计和应用。

相似文献

1
Harnessing immune responses against Plasmodium for rational vaccine design.利用针对疟原虫的免疫应答进行合理的疫苗设计。
Trends Parasitol. 2011 Jun;27(6):274-83. doi: 10.1016/j.pt.2011.01.002. Epub 2011 Apr 30.
2
Exoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.红细胞外期疟疾疫苗的研发:理解宿主-寄生虫免疫生物学是战略成功的关键。
Expert Rev Vaccines. 2002 Oct;1(3):317-40. doi: 10.1586/14760584.1.3.317.
3
Targeting Plasmodium liver stages: better late than never.靶向疟原虫肝期:亡羊补牢,为时未晚。
Trends Mol Med. 2011 Sep;17(9):527-36. doi: 10.1016/j.molmed.2011.05.008. Epub 2011 Jul 6.
4
Immune evasion by malaria parasites: a challenge for vaccine development.疟原虫的免疫逃避:疫苗研发面临的挑战
Curr Opin Immunol. 2009 Jun;21(3):321-30. doi: 10.1016/j.coi.2009.05.015. Epub 2009 Jun 1.
5
A whole parasite vaccine to control the blood stages of Plasmodium: the case for lateral thinking.一种控制疟原虫血期的全寄生虫疫苗:横向思维的案例。
Trends Parasitol. 2011 Aug;27(8):335-40. doi: 10.1016/j.pt.2011.03.003. Epub 2011 Apr 21.
6
Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.先天免疫对疟疾的寄生虫识别和信号转导机制。
Front Immunol. 2018 Dec 19;9:3006. doi: 10.3389/fimmu.2018.03006. eCollection 2018.
7
Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.转基因疟原虫凸显了全寄生虫疫苗策略的潜力。
Trends Immunol. 2005 Jun;26(6):295-7. doi: 10.1016/j.it.2005.04.005.
8
Immune responses to liver-stage parasites: implications for vaccine development.对肝期寄生虫的免疫反应:对疫苗开发的启示。
Chem Immunol. 2002;80:97-124. doi: 10.1159/000058841.
9
Preerythrocytic malaria vaccine development.疟原虫前体细胞疫苗的研发。
Curr Opin Infect Dis. 2007 Oct;20(5):461-6. doi: 10.1097/QCO.0b013e3282ef6172.
10
High road, low road? Choices and challenges on the pathway to a malaria vaccine.阳关大道还是羊肠小道?疟疾疫苗研发之路的选择与挑战
Parasitology. 2006;133 Suppl:S113-44. doi: 10.1017/S0031182006001843.

引用本文的文献

1
A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with .一项组织形态计量学研究,以评估生物合成的银纳米颗粒对感染……的肾脏的治疗效果。 (原文中“infected with”后缺少具体感染物)
Open Life Sci. 2024 Oct 23;19(1):20220968. doi: 10.1515/biol-2022-0968. eCollection 2024.
2
Recombinant DBL2β-PfEMP1 of the Indonesian induces immune responses in Wistar rats.印度尼西亚重组DBL2β-PfEMP1在Wistar大鼠中诱导免疫反应。
J Taibah Univ Med Sci. 2021 Jan 15;16(3):422-430. doi: 10.1016/j.jtumed.2020.12.007. eCollection 2021 Jun.
3
OX40 Stimulation Enhances Protective Immune Responses Induced After Vaccination With Attenuated Malaria Parasites.
OX40 刺激增强减毒疟原虫疫苗接种后诱导的保护性免疫应答。
Front Cell Infect Microbiol. 2018 Jul 19;8:247. doi: 10.3389/fcimb.2018.00247. eCollection 2018.
4
P2X7 receptor drives Th1 cell differentiation and controls the follicular helper T cell population to protect against Plasmodium chabaudi malaria.P2X7受体驱动Th1细胞分化并控制滤泡辅助性T细胞群体,以抵御恰氏疟原虫疟疾。
PLoS Pathog. 2017 Aug 31;13(8):e1006595. doi: 10.1371/journal.ppat.1006595. eCollection 2017 Aug.
5
Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production.疟原虫寄生虫负担降低与具有细胞溶解潜力且干扰素-γ产生受损的CD38+ CD4+ T细胞相关。
PLoS Pathog. 2016 Sep 23;12(9):e1005839. doi: 10.1371/journal.ppat.1005839. eCollection 2016 Sep.
6
Ethnomedicines and anti-parasitic activities of Pakistani medicinal plants against Plasmodia and Leishmania parasites.巴基斯坦药用植物对疟原虫和利什曼原虫的民族医学及抗寄生虫活性。
Ann Clin Microbiol Antimicrob. 2016 Sep 20;15(1):52. doi: 10.1186/s12941-016-0170-0.
7
CD4+ T cell response correlates with naturally acquired antibodies against Plasmodium vivax tryptophan-rich antigens.CD4 + T细胞反应与针对间日疟原虫富含色氨酸抗原的自然获得性抗体相关。
Infect Immun. 2015 May;83(5):2018-29. doi: 10.1128/IAI.03095-14. Epub 2015 Mar 2.
8
Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance.靶向疟原虫热休克蛋白 90:逆转抗疟耐药。
Pathogens. 2013 Feb 4;2(1):33-54. doi: 10.3390/pathogens2010033.
9
Immunogenicity of a prime-boost vaccine containing the circumsporozoite proteins of Plasmodium vivax in rodents.含间日疟原虫环子孢子蛋白的初免-加强疫苗在啮齿动物中的免疫原性。
Infect Immun. 2014 Feb;82(2):793-807. doi: 10.1128/IAI.01410-13. Epub 2013 Dec 9.
10
Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer.碳纳米管作为一种新型工具,可用于预防传染病和癌症的疫苗接种。
J Nanobiotechnology. 2013 Sep 11;11:30. doi: 10.1186/1477-3155-11-30.